| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulosclerosis, Focal Segmental | 64 | 2023 | 357 | 14.350 |
Why?
|
| Podocytes | 34 | 2022 | 396 | 6.890 |
Why?
|
| Apolipoproteins | 29 | 2023 | 317 | 6.470 |
Why?
|
| Actinin | 23 | 2020 | 160 | 5.750 |
Why?
|
| Lipoproteins, HDL | 26 | 2016 | 640 | 5.450 |
Why?
|
| Kidney Diseases | 28 | 2022 | 2146 | 4.650 |
Why?
|
| Microfilament Proteins | 17 | 2016 | 1152 | 3.250 |
Why?
|
| Kidney Glomerulus | 16 | 2021 | 697 | 2.180 |
Why?
|
| Nephrotic Syndrome | 13 | 2023 | 389 | 2.060 |
Why?
|
| Receptors, Calcium-Sensing | 25 | 2018 | 315 | 1.950 |
Why?
|
| AIDS-Associated Nephropathy | 6 | 2021 | 35 | 1.460 |
Why?
|
| Actins | 15 | 2020 | 2121 | 1.310 |
Why?
|
| Calcium | 33 | 2018 | 5755 | 1.170 |
Why?
|
| Renal Insufficiency, Chronic | 11 | 2022 | 2200 | 1.110 |
Why?
|
| Mutation | 42 | 2021 | 29777 | 1.100 |
Why?
|
| Genetic Variation | 17 | 2020 | 6535 | 1.000 |
Why?
|
| Molecular Motor Proteins | 5 | 2015 | 107 | 0.990 |
Why?
|
| Proteinuria | 7 | 2023 | 658 | 0.970 |
Why?
|
| Kidney | 27 | 2022 | 7185 | 0.940 |
Why?
|
| TRPC Cation Channels | 6 | 2012 | 121 | 0.940 |
Why?
|
| Genetic Predisposition to Disease | 34 | 2023 | 17439 | 0.940 |
Why?
|
| Point Mutation | 8 | 2018 | 1623 | 0.940 |
Why?
|
| Myosin Heavy Chains | 6 | 2015 | 414 | 0.910 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2023 | 15518 | 0.890 |
Why?
|
| Pedigree | 22 | 2020 | 4643 | 0.870 |
Why?
|
| Membrane Proteins | 15 | 2022 | 7880 | 0.850 |
Why?
|
| Mutation, Missense | 7 | 2019 | 2566 | 0.810 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2020 | 25 | 0.770 |
Why?
|
| Albuminuria | 4 | 2020 | 681 | 0.750 |
Why?
|
| Parathyroid Hormone | 13 | 2018 | 1800 | 0.740 |
Why?
|
| Glomerular Filtration Rate | 5 | 2020 | 2167 | 0.730 |
Why?
|
| Kidney Failure, Chronic | 11 | 2020 | 2534 | 0.710 |
Why?
|
| Hypercalcemia | 13 | 2018 | 409 | 0.600 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 9 | 2016 | 2914 | 0.590 |
Why?
|
| Gene Frequency | 10 | 2016 | 3585 | 0.580 |
Why?
|
| Ubiquitins | 1 | 2018 | 384 | 0.550 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 1986 | 0.540 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2016 | 241 | 0.530 |
Why?
|
| Ion Transport | 1 | 2015 | 320 | 0.500 |
Why?
|
| Animals | 80 | 2023 | 168660 | 0.490 |
Why?
|
| Gene Duplication | 2 | 2015 | 328 | 0.490 |
Why?
|
| Receptors, Cell Surface | 14 | 2003 | 2865 | 0.490 |
Why?
|
| Phenotype | 18 | 2021 | 16361 | 0.470 |
Why?
|
| PAX2 Transcription Factor | 1 | 2014 | 80 | 0.470 |
Why?
|
| Humans | 157 | 2023 | 743811 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2015 | 535 | 0.460 |
Why?
|
| Hyperparathyroidism | 11 | 2018 | 339 | 0.460 |
Why?
|
| Homozygote | 9 | 2015 | 1787 | 0.460 |
Why?
|
| HEK293 Cells | 11 | 2023 | 4204 | 0.460 |
Why?
|
| Glomerulonephritis | 3 | 2018 | 372 | 0.460 |
Why?
|
| Trypanosoma brucei rhodesiense | 3 | 2016 | 12 | 0.450 |
Why?
|
| Trypanosomiasis, African | 4 | 2016 | 28 | 0.450 |
Why?
|
| Amino Acid Substitution | 5 | 2015 | 1793 | 0.450 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 457 | 0.440 |
Why?
|
| Potassium | 2 | 2020 | 1336 | 0.430 |
Why?
|
| Genotype | 22 | 2023 | 12944 | 0.430 |
Why?
|
| Alleles | 12 | 2020 | 6934 | 0.430 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 541 | 0.430 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 318 | 0.430 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.420 |
Why?
|
| Genes, Dominant | 5 | 2013 | 880 | 0.420 |
Why?
|
| Mice | 51 | 2023 | 81154 | 0.420 |
Why?
|
| Genetic Testing | 7 | 2022 | 3439 | 0.420 |
Why?
|
| Chromosome Disorders | 1 | 2015 | 510 | 0.420 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2016 | 547 | 0.410 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 2006 | 0.410 |
Why?
|
| Africa | 5 | 2020 | 672 | 0.410 |
Why?
|
| Chromosome Mapping | 7 | 2013 | 4737 | 0.400 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2011 | 90 | 0.400 |
Why?
|
| Integrin beta3 | 1 | 2011 | 122 | 0.380 |
Why?
|
| DNA Mutational Analysis | 10 | 2019 | 4183 | 0.380 |
Why?
|
| Autophagy | 1 | 2019 | 1296 | 0.380 |
Why?
|
| Zebrafish Proteins | 3 | 2016 | 1005 | 0.380 |
Why?
|
| Consanguinity | 3 | 2013 | 455 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 1284 | 0.370 |
Why?
|
| Long QT Syndrome | 1 | 2015 | 453 | 0.370 |
Why?
|
| Nephritis, Hereditary | 2 | 2022 | 88 | 0.370 |
Why?
|
| Gene Dosage | 1 | 2015 | 1252 | 0.370 |
Why?
|
| Haplotypes | 12 | 2023 | 2779 | 0.360 |
Why?
|
| Muscle Proteins | 1 | 2015 | 1158 | 0.360 |
Why?
|
| Heterozygote | 8 | 2015 | 2803 | 0.350 |
Why?
|
| Biological Evolution | 2 | 2014 | 1079 | 0.340 |
Why?
|
| Glutamyl Aminopeptidase | 1 | 2007 | 3 | 0.320 |
Why?
|
| Parathyroid Glands | 11 | 2018 | 509 | 0.310 |
Why?
|
| Kidney Calculi | 3 | 2020 | 465 | 0.310 |
Why?
|
| NFATC Transcription Factors | 2 | 2012 | 381 | 0.310 |
Why?
|
| Cells, Cultured | 14 | 2020 | 19232 | 0.310 |
Why?
|
| Kidney Diseases, Cystic | 2 | 2018 | 186 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2000 | 367 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2008 | 351 | 0.300 |
Why?
|
| Hypocalcemia | 3 | 2018 | 191 | 0.300 |
Why?
|
| Peptide Fragments | 2 | 2020 | 5096 | 0.300 |
Why?
|
| Carrier Proteins | 3 | 2021 | 5021 | 0.300 |
Why?
|
| Protein Binding | 10 | 2020 | 9377 | 0.290 |
Why?
|
| Homeostasis | 15 | 2018 | 3337 | 0.290 |
Why?
|
| Genes, Recessive | 5 | 2019 | 641 | 0.290 |
Why?
|
| Mice, Transgenic | 9 | 2022 | 9731 | 0.290 |
Why?
|
| Amino Acid Sequence | 16 | 2016 | 13809 | 0.290 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1937 | 0.280 |
Why?
|
| Kidney Tubules | 3 | 2018 | 488 | 0.280 |
Why?
|
| Molecular Sequence Data | 17 | 2015 | 18107 | 0.280 |
Why?
|
| Age of Onset | 6 | 2019 | 3268 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2014 | 2916 | 0.270 |
Why?
|
| Claudins | 3 | 2017 | 111 | 0.270 |
Why?
|
| Kidney Transplantation | 5 | 2022 | 4251 | 0.270 |
Why?
|
| Genomics | 3 | 2020 | 5714 | 0.270 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 1996 | 0.260 |
Why?
|
| Microscopy, Electron | 6 | 2012 | 2646 | 0.260 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 805 | 0.260 |
Why?
|
| Phosphorylation | 5 | 2020 | 8436 | 0.260 |
Why?
|
| Cytoskeleton | 4 | 2018 | 1185 | 0.260 |
Why?
|
| Female | 62 | 2022 | 380020 | 0.250 |
Why?
|
| Laminin | 1 | 2006 | 419 | 0.250 |
Why?
|
| Hypertension | 6 | 2022 | 8480 | 0.250 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2015 | 1723 | 0.250 |
Why?
|
| Atherosclerosis | 3 | 2015 | 3445 | 0.250 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 1968 | 0.250 |
Why?
|
| Risk Factors | 22 | 2023 | 72252 | 0.240 |
Why?
|
| Male | 53 | 2022 | 349776 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2016 | 2839 | 0.230 |
Why?
|
| Health Status Disparities | 1 | 2015 | 1796 | 0.230 |
Why?
|
| Base Sequence | 8 | 2014 | 12798 | 0.230 |
Why?
|
| Protein Transport | 3 | 2020 | 1988 | 0.230 |
Why?
|
| Nephrosis | 1 | 2003 | 45 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2018 | 1222 | 0.220 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2022 | 22 | 0.210 |
Why?
|
| Collagen Type IV | 4 | 2022 | 140 | 0.210 |
Why?
|
| Genome, Human | 5 | 2015 | 4418 | 0.210 |
Why?
|
| Diabetic Nephropathies | 3 | 2020 | 984 | 0.210 |
Why?
|
| Gene Expression Regulation | 11 | 2017 | 12066 | 0.200 |
Why?
|
| Phosphorus | 3 | 2012 | 338 | 0.200 |
Why?
|
| Conserved Sequence | 4 | 2014 | 1202 | 0.200 |
Why?
|
| Coronary Disease | 2 | 2018 | 6078 | 0.200 |
Why?
|
| Mice, Knockout | 16 | 2017 | 14563 | 0.200 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2021 | 126 | 0.200 |
Why?
|
| RNA, Messenger | 8 | 2022 | 13028 | 0.200 |
Why?
|
| Calcium Channels | 1 | 2005 | 622 | 0.200 |
Why?
|
| Intranuclear Space | 1 | 2021 | 15 | 0.200 |
Why?
|
| Cross-Linking Reagents | 3 | 2015 | 694 | 0.200 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9648 | 0.200 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2020 | 22 | 0.200 |
Why?
|
| Transcription Factors | 3 | 2016 | 12209 | 0.190 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2021 | 73 | 0.190 |
Why?
|
| Hyperoxaluria | 1 | 2020 | 32 | 0.190 |
Why?
|
| Risk | 4 | 2015 | 9677 | 0.190 |
Why?
|
| Adult | 39 | 2022 | 213889 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 712 | 0.190 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 241 | 0.190 |
Why?
|
| Peptidomimetics | 1 | 2020 | 34 | 0.180 |
Why?
|
| Calcium Oxalate | 1 | 2020 | 74 | 0.180 |
Why?
|
| Adolescent | 19 | 2021 | 85729 | 0.180 |
Why?
|
| Bartter Syndrome | 2 | 1996 | 24 | 0.180 |
Why?
|
| Endosomes | 2 | 2022 | 518 | 0.180 |
Why?
|
| Models, Genetic | 2 | 2008 | 3492 | 0.180 |
Why?
|
| Calcium Metabolism Disorders | 1 | 1999 | 11 | 0.180 |
Why?
|
| Models, Chemical | 3 | 2013 | 626 | 0.180 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 15142 | 0.180 |
Why?
|
| Calcium Signaling | 4 | 2014 | 721 | 0.180 |
Why?
|
| Recombination, Genetic | 3 | 2013 | 1586 | 0.170 |
Why?
|
| Heredity | 1 | 2020 | 154 | 0.170 |
Why?
|
| Pregnancy Complications | 3 | 2019 | 2861 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3510 | 0.170 |
Why?
|
| Bone Remodeling | 2 | 2014 | 569 | 0.170 |
Why?
|
| Calcium, Dietary | 5 | 2018 | 525 | 0.170 |
Why?
|
| Nonmuscle Myosin Type IIA | 2 | 2016 | 26 | 0.170 |
Why?
|
| Cathepsins | 1 | 2020 | 238 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 11729 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2022 | 541 | 0.160 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 201 | 0.160 |
Why?
|
| Drug Resistance | 2 | 2013 | 1606 | 0.160 |
Why?
|
| Cell Line | 10 | 2021 | 15993 | 0.160 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2703 | 0.160 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2019 | 154 | 0.160 |
Why?
|
| Case-Control Studies | 8 | 2020 | 21733 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 5867 | 0.160 |
Why?
|
| Hypercalciuria | 2 | 2015 | 31 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2000 | 657 | 0.160 |
Why?
|
| Transfection | 3 | 2015 | 5892 | 0.160 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 1940 | 0.150 |
Why?
|
| Cell Adhesion | 3 | 2018 | 3144 | 0.150 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 309 | 0.150 |
Why?
|
| Steroids | 1 | 2003 | 930 | 0.150 |
Why?
|
| Living Donors | 1 | 2022 | 621 | 0.150 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 2877 | 0.150 |
Why?
|
| Human Genome Project | 2 | 2015 | 193 | 0.150 |
Why?
|
| Proteoglycans | 1 | 2020 | 837 | 0.150 |
Why?
|
| Models, Molecular | 4 | 2014 | 5445 | 0.150 |
Why?
|
| Cell Movement | 5 | 2016 | 5216 | 0.150 |
Why?
|
| Recombinant Proteins | 4 | 2019 | 6620 | 0.140 |
Why?
|
| False Positive Reactions | 1 | 2019 | 980 | 0.140 |
Why?
|
| Genetic Linkage | 6 | 2013 | 2419 | 0.140 |
Why?
|
| Glucuronidase | 1 | 2018 | 207 | 0.140 |
Why?
|
| Receptors, Drug | 1 | 1996 | 161 | 0.140 |
Why?
|
| Proteins | 3 | 2007 | 6098 | 0.140 |
Why?
|
| Nephrectomy | 2 | 2020 | 1048 | 0.140 |
Why?
|
| Serine | 1 | 2020 | 825 | 0.140 |
Why?
|
| Protamines | 1 | 2016 | 106 | 0.140 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2015 | 66 | 0.140 |
Why?
|
| Middle Aged | 28 | 2022 | 213241 | 0.140 |
Why?
|
| Disclosure | 1 | 2022 | 737 | 0.130 |
Why?
|
| Immunoprecipitation | 3 | 2018 | 906 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7719 | 0.130 |
Why?
|
| Young Adult | 11 | 2021 | 56392 | 0.130 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 428 | 0.130 |
Why?
|
| Static Electricity | 2 | 2014 | 263 | 0.130 |
Why?
|
| Child | 16 | 2023 | 77637 | 0.130 |
Why?
|
| Models, Biological | 4 | 2015 | 9582 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 21824 | 0.130 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2017 | 307 | 0.130 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2015 | 56 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 3772 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3847 | 0.130 |
Why?
|
| Insulin | 1 | 2010 | 6584 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 352 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 602 | 0.130 |
Why?
|
| Cyclosporins | 1 | 2015 | 220 | 0.130 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2016 | 129 | 0.130 |
Why?
|
| Disease Models, Animal | 9 | 2016 | 18027 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2020 | 1729 | 0.130 |
Why?
|
| Mesangial Cells | 1 | 2014 | 24 | 0.120 |
Why?
|
| Lod Score | 4 | 2005 | 613 | 0.120 |
Why?
|
| Elasticity | 3 | 2013 | 657 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 293 | 0.120 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2009 | 429 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 3 | 2014 | 1364 | 0.120 |
Why?
|
| Tight Junctions | 1 | 2017 | 311 | 0.120 |
Why?
|
| Binding Sites | 3 | 2015 | 6111 | 0.120 |
Why?
|
| Cell Death | 2 | 2019 | 1705 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 5 | 2013 | 4803 | 0.120 |
Why?
|
| Glycosuria, Renal | 1 | 2013 | 4 | 0.120 |
Why?
|
| Kinetics | 2 | 2015 | 6476 | 0.120 |
Why?
|
| Alkaptonuria | 1 | 1993 | 13 | 0.120 |
Why?
|
| Lysosomes | 1 | 2019 | 893 | 0.120 |
Why?
|
| Cell Size | 1 | 2015 | 641 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2692 | 0.120 |
Why?
|
| Symporters | 1 | 1996 | 362 | 0.110 |
Why?
|
| Signal Transduction | 12 | 2017 | 23398 | 0.110 |
Why?
|
| Polyuria | 1 | 2013 | 39 | 0.110 |
Why?
|
| Disease Progression | 6 | 2015 | 13273 | 0.110 |
Why?
|
| Magnesium | 2 | 2013 | 813 | 0.110 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2012 | 464 | 0.110 |
Why?
|
| Estrogen Antagonists | 1 | 1993 | 151 | 0.110 |
Why?
|
| Euchromatin | 1 | 2013 | 56 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2009 | 1952 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1677 | 0.110 |
Why?
|
| Renin-Angiotensin System | 2 | 2008 | 758 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 5 | 2007 | 1081 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1146 | 0.110 |
Why?
|
| Mycophenolic Acid | 1 | 2015 | 343 | 0.110 |
Why?
|
| Bone and Bones | 4 | 2018 | 2576 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1993 | 323 | 0.110 |
Why?
|
| Pseudopodia | 1 | 2013 | 172 | 0.110 |
Why?
|
| Aged | 17 | 2021 | 163178 | 0.110 |
Why?
|
| Disease | 2 | 2014 | 680 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1862 | 0.110 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 3504 | 0.110 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2012 | 102 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2503 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2013 | 188 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 1452 | 0.100 |
Why?
|
| Minisatellite Repeats | 1 | 2013 | 165 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2014 | 416 | 0.100 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 204 | 0.100 |
Why?
|
| Rabbits | 3 | 2013 | 4894 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2012 | 43 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 436 | 0.100 |
Why?
|
| Protein Conformation | 4 | 2016 | 4009 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4749 | 0.100 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2012 | 144 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1962 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 386 | 0.100 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 168 | 0.100 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 897 | 0.100 |
Why?
|
| Haploidy | 1 | 2011 | 136 | 0.100 |
Why?
|
| Luciferases | 2 | 2011 | 733 | 0.100 |
Why?
|
| DNA, Complementary | 4 | 2003 | 2050 | 0.100 |
Why?
|
| Extremities | 1 | 2017 | 867 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 873 | 0.100 |
Why?
|
| Dimerization | 1 | 2013 | 894 | 0.100 |
Why?
|
| Cytosol | 2 | 2013 | 901 | 0.100 |
Why?
|
| Gastrin-Secreting Cells | 1 | 2010 | 2 | 0.100 |
Why?
|
| HeLa Cells | 2 | 2015 | 3130 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 261 | 0.100 |
Why?
|
| Postmenopause | 2 | 2018 | 2458 | 0.100 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2011 | 164 | 0.100 |
Why?
|
| Gastrins | 1 | 2010 | 81 | 0.100 |
Why?
|
| Stress Fibers | 1 | 2010 | 57 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 1552 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2019 | 2440 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1996 | 582 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 798 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2014 | 2961 | 0.090 |
Why?
|
| Heterochromatin | 1 | 2013 | 296 | 0.090 |
Why?
|
| Polymerization | 1 | 2011 | 164 | 0.090 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 12259 | 0.090 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2014 | 427 | 0.090 |
Why?
|
| DNA Primers | 2 | 2011 | 2891 | 0.090 |
Why?
|
| Kidney Function Tests | 3 | 2020 | 684 | 0.090 |
Why?
|
| Gelsolin | 1 | 2010 | 190 | 0.090 |
Why?
|
| Biopolymers | 1 | 2010 | 189 | 0.090 |
Why?
|
| Elastic Modulus | 1 | 2010 | 214 | 0.090 |
Why?
|
| Dynamins | 1 | 2010 | 152 | 0.090 |
Why?
|
| Polymorphism, Genetic | 4 | 2014 | 4326 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2015 | 3701 | 0.090 |
Why?
|
| Zebrafish | 3 | 2016 | 2995 | 0.090 |
Why?
|
| Uterus | 1 | 1993 | 711 | 0.090 |
Why?
|
| Bioengineering | 2 | 2021 | 99 | 0.090 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2009 | 24 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 676 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 4561 | 0.080 |
Why?
|
| Tooth Socket | 1 | 2010 | 115 | 0.080 |
Why?
|
| Uremia | 1 | 2010 | 200 | 0.080 |
Why?
|
| Tamoxifen | 1 | 1993 | 981 | 0.080 |
Why?
|
| Child, Preschool | 6 | 2021 | 40964 | 0.080 |
Why?
|
| Cause of Death | 2 | 2018 | 3580 | 0.080 |
Why?
|
| Heparin | 1 | 2016 | 1637 | 0.080 |
Why?
|
| Chromones | 1 | 2009 | 154 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2020 | 40545 | 0.080 |
Why?
|
| Incidence | 5 | 2018 | 20948 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2007 | 5179 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 688 | 0.080 |
Why?
|
| Tooth | 1 | 2010 | 204 | 0.080 |
Why?
|
| Cloning, Molecular | 9 | 2016 | 4320 | 0.080 |
Why?
|
| Dogs | 1 | 2013 | 3911 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1524 | 0.080 |
Why?
|
| Ergocalciferols | 1 | 2009 | 110 | 0.080 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2010 | 331 | 0.080 |
Why?
|
| Mucin-1 | 1 | 2013 | 544 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1434 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 173 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 498 | 0.080 |
Why?
|
| Glucose | 1 | 2020 | 4398 | 0.080 |
Why?
|
| Calcineurin | 1 | 2009 | 226 | 0.080 |
Why?
|
| Benzylamines | 1 | 2009 | 223 | 0.080 |
Why?
|
| Genetics, Population | 1 | 2013 | 933 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 4463 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 390 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2015 | 1950 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6539 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2013 | 2256 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 2010 | 435 | 0.070 |
Why?
|
| Proteomics | 1 | 2020 | 3639 | 0.070 |
Why?
|
| Glycosylation | 2 | 2009 | 1129 | 0.070 |
Why?
|
| Glomerular Basement Membrane | 1 | 2006 | 33 | 0.070 |
Why?
|
| Exons | 2 | 2003 | 2438 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 878 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2013 | 1640 | 0.070 |
Why?
|
| Biopsy | 4 | 2014 | 6750 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2010 | 10477 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 1 | 2006 | 183 | 0.070 |
Why?
|
| Viscosity | 3 | 2013 | 328 | 0.070 |
Why?
|
| Osteogenesis | 2 | 2011 | 1291 | 0.070 |
Why?
|
| Estradiol | 1 | 1993 | 2017 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2013 | 3749 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2009 | 788 | 0.070 |
Why?
|
| Duodenum | 1 | 2009 | 484 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1524 | 0.070 |
Why?
|
| Basement Membrane | 1 | 2006 | 357 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1993 | 2017 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2011 | 942 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2016 | 2119 | 0.070 |
Why?
|
| Morpholines | 1 | 2009 | 571 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2015 | 2575 | 0.070 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1137 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2018 | 5002 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2010 | 914 | 0.060 |
Why?
|
| Epilepsy | 1 | 2021 | 3284 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 319 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2013 | 2749 | 0.060 |
Why?
|
| Renal Dialysis | 2 | 2011 | 1783 | 0.060 |
Why?
|
| Hematuria | 2 | 2022 | 235 | 0.060 |
Why?
|
| Gene Expression | 2 | 2015 | 7793 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2014 | 6188 | 0.060 |
Why?
|
| Gene Components | 1 | 2004 | 29 | 0.060 |
Why?
|
| Rats | 4 | 2013 | 24250 | 0.060 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 399 | 0.060 |
Why?
|
| Porosity | 2 | 2018 | 360 | 0.060 |
Why?
|
| Intercellular Junctions | 1 | 2005 | 203 | 0.060 |
Why?
|
| Epithelial Cells | 4 | 2018 | 3690 | 0.060 |
Why?
|
| Fasting | 1 | 2010 | 1590 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1656 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 2007 | 386 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 142 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 11360 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3917 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 417 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2004 | 245 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2013 | 4162 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 620 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2014 | 4197 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2013 | 2455 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2008 | 726 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 40038 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2006 | 607 | 0.060 |
Why?
|
| Extracellular Space | 2 | 1995 | 595 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4459 | 0.060 |
Why?
|
| Endocytosis | 2 | 2022 | 985 | 0.060 |
Why?
|
| Carcinoma | 2 | 2010 | 2375 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12354 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2021 | 53250 | 0.060 |
Why?
|
| Health | 2 | 2014 | 394 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2419 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3482 | 0.050 |
Why?
|
| Liver | 2 | 2016 | 7479 | 0.050 |
Why?
|
| United States | 6 | 2022 | 69859 | 0.050 |
Why?
|
| Creatinine | 2 | 2023 | 1918 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2007 | 1168 | 0.050 |
Why?
|
| Inosine | 1 | 2022 | 133 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2006 | 1536 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2005 | 572 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1900 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2008 | 2634 | 0.050 |
Why?
|
| Graft Survival | 1 | 2012 | 3734 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2005 | 1263 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1581 | 0.050 |
Why?
|
| RNA Editing | 1 | 2022 | 148 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 18355 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 6170 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2022 | 290 | 0.050 |
Why?
|
| Aptamers, Peptide | 1 | 2020 | 28 | 0.050 |
Why?
|
| Xenopus laevis | 2 | 2015 | 956 | 0.050 |
Why?
|
| Neoplasms | 1 | 2010 | 21675 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2014 | 500 | 0.050 |
Why?
|
| Fucose | 1 | 2021 | 126 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1800 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 513 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 1205 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2020 | 2123 | 0.050 |
Why?
|
| Probability | 1 | 2005 | 2505 | 0.040 |
Why?
|
| Galactose | 1 | 2021 | 306 | 0.040 |
Why?
|
| Cell Shape | 2 | 2011 | 375 | 0.040 |
Why?
|
| Hyperplasia | 3 | 2018 | 1185 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 281 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3463 | 0.040 |
Why?
|
| Family | 1 | 2010 | 3144 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2009 | 1938 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2007 | 1253 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2019 | 199 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 4925 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2008 | 1211 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2003 | 2327 | 0.040 |
Why?
|
| Logistic Models | 2 | 2010 | 13404 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2013 | 2649 | 0.040 |
Why?
|
| Syndrome | 2 | 2002 | 3249 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2021 | 2500 | 0.040 |
Why?
|
| Calcitonin | 2 | 2009 | 336 | 0.040 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2018 | 149 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3794 | 0.040 |
Why?
|
| Ion Channels | 1 | 2022 | 1056 | 0.040 |
Why?
|
| Cell Membrane Permeability | 2 | 2013 | 589 | 0.040 |
Why?
|
| Family Health | 2 | 2005 | 1280 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 825 | 0.040 |
Why?
|
| RNA Interference | 2 | 2019 | 2890 | 0.040 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 86 | 0.040 |
Why?
|
| Organ Size | 2 | 2011 | 2241 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2015 | 23327 | 0.040 |
Why?
|
| Sodium Chloride Symporters | 1 | 1996 | 11 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 697 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2000 | 675 | 0.040 |
Why?
|
| Body Weight | 2 | 2010 | 4670 | 0.040 |
Why?
|
| Attitude | 1 | 2022 | 775 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 2086 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 2018 | 371 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 2 | 1996 | 288 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2013 | 1684 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2006 | 5973 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2016 | 353 | 0.030 |
Why?
|
| Hypokalemia | 1 | 1996 | 153 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2002 | 1237 | 0.030 |
Why?
|
| Tetany | 1 | 1994 | 12 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8655 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2003 | 2615 | 0.030 |
Why?
|
| Drosophila | 1 | 2022 | 1494 | 0.030 |
Why?
|
| Mandrillus | 1 | 2014 | 3 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 114 | 0.030 |
Why?
|
| Prevalence | 1 | 2011 | 15211 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 3503 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 11708 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 1999 | 536 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10896 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2019 | 971 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2014 | 101 | 0.030 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1993 | 13 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 626 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 504 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 90 | 0.030 |
Why?
|
| Necrosis | 1 | 2018 | 1642 | 0.030 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 245 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3205 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 2119 | 0.030 |
Why?
|
| Osmosis | 1 | 2013 | 113 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 409 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2013 | 85 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 3389 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 506 | 0.030 |
Why?
|
| Comorbidity | 1 | 2007 | 10380 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 2014 | 246 | 0.030 |
Why?
|
| England | 1 | 2014 | 522 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5752 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2018 | 1340 | 0.030 |
Why?
|
| Oocytes | 2 | 1995 | 1186 | 0.030 |
Why?
|
| Receptors, CCR2 | 2 | 2006 | 212 | 0.030 |
Why?
|
| Nephrology | 1 | 2016 | 263 | 0.030 |
Why?
|
| Cations | 1 | 2013 | 232 | 0.030 |
Why?
|
| Papio | 1 | 2014 | 656 | 0.030 |
Why?
|
| Genes, src | 1 | 2012 | 52 | 0.030 |
Why?
|
| Body Composition | 1 | 2021 | 2401 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| Cisplatin | 1 | 2018 | 1662 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 142 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2014 | 360 | 0.030 |
Why?
|
| Geography | 1 | 2014 | 669 | 0.030 |
Why?
|
| Cytosine | 1 | 2013 | 216 | 0.030 |
Why?
|
| Pregnancy | 3 | 2019 | 29140 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 2019 | 25609 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9440 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2014 | 338 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2016 | 1233 | 0.020 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2010 | 20 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2014 | 592 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 8300 | 0.020 |
Why?
|
| Bombesin | 1 | 2010 | 34 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2010 | 68 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 262 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 781 | 0.020 |
Why?
|
| Software | 1 | 2005 | 4440 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1743 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 2010 | 50 | 0.020 |
Why?
|
| Monocytes | 1 | 2000 | 2593 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 732 | 0.020 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 670 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 237 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14714 | 0.020 |
Why?
|
| Dicarboxylic Acids | 1 | 2010 | 69 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 501 | 0.020 |
Why?
|
| Cell Survival | 1 | 2020 | 5881 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2010 | 61 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 2010 | 106 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2010 | 194 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2010 | 211 | 0.020 |
Why?
|
| Rheology | 1 | 2010 | 345 | 0.020 |
Why?
|
| Genes | 1 | 1993 | 1893 | 0.020 |
Why?
|
| Calcitriol | 1 | 2011 | 297 | 0.020 |
Why?
|
| Lysine | 1 | 2014 | 1007 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 577 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2899 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 2794 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2009 | 273 | 0.020 |
Why?
|
| Periodicity | 1 | 2010 | 364 | 0.020 |
Why?
|
| Drug Implants | 1 | 2009 | 241 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 424 | 0.020 |
Why?
|
| Calcifediol | 1 | 2009 | 166 | 0.020 |
Why?
|
| Bone Density | 2 | 2012 | 3460 | 0.020 |
Why?
|
| Health Personnel | 1 | 2022 | 3217 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 449 | 0.020 |
Why?
|
| Infant | 2 | 2008 | 35122 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 302 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 420 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2007 | 182 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11059 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 3921 | 0.020 |
Why?
|
| Nucleotides | 1 | 2010 | 463 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 1683 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2011 | 722 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2007 | 420 | 0.020 |
Why?
|
| Neurons | 1 | 2006 | 9336 | 0.020 |
Why?
|
| Hormones | 1 | 2011 | 889 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 1728 | 0.020 |
Why?
|
| Vitamin D | 2 | 2013 | 3222 | 0.020 |
Why?
|
| Mortality | 1 | 2018 | 2862 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 892 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2013 | 851 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 63042 | 0.020 |
Why?
|
| Phenols | 1 | 2010 | 496 | 0.020 |
Why?
|
| Second Messenger Systems | 2 | 1998 | 206 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2004 | 5033 | 0.020 |
Why?
|
| Phosphates | 1 | 2009 | 784 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 1725 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2556 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 2725 | 0.020 |
Why?
|
| Femur | 1 | 2012 | 1296 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2011 | 1164 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29052 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1030 | 0.020 |
Why?
|
| KCNQ Potassium Channels | 1 | 2004 | 18 | 0.020 |
Why?
|
| Adenoma | 1 | 1995 | 2173 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4221 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2004 | 104 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1854 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2883 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 1917 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1245 | 0.020 |
Why?
|
| Diphosphonates | 1 | 2009 | 622 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2013 | 1709 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 25032 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 1545 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 2509 | 0.010 |
Why?
|
| Amino Acids | 1 | 2009 | 1733 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 2011 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 3769 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39001 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3547 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1855 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2011 | 2506 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2453 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9718 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2014 | 3587 | 0.010 |
Why?
|
| Intestines | 1 | 2011 | 1923 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3706 | 0.010 |
Why?
|
| RNA | 1 | 2012 | 2748 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6380 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 2008 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3515 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3513 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12786 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 3591 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3038 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2359 | 0.010 |
Why?
|
| Cattle | 2 | 1995 | 3917 | 0.010 |
Why?
|
| Obesity | 1 | 2021 | 12744 | 0.010 |
Why?
|
| Cytokines | 1 | 2013 | 7324 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 8337 | 0.010 |
Why?
|
| Kidney Concentrating Ability | 1 | 1998 | 41 | 0.010 |
Why?
|
| Fetus | 1 | 2005 | 1880 | 0.010 |
Why?
|
| Absorption | 1 | 1998 | 248 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12954 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15067 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1998 | 166 | 0.010 |
Why?
|
| Stem Cells | 1 | 2011 | 3566 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1998 | 186 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1998 | 182 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13980 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 10251 | 0.010 |
Why?
|
| Retina | 1 | 2008 | 2612 | 0.010 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1998 | 178 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15526 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9944 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2005 | 2073 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 878 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 2021 | 0.010 |
Why?
|
| Stroke | 1 | 2018 | 9975 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13691 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1995 | 284 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1995 | 130 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1995 | 292 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 4152 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11478 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 1374 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16674 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1998 | 588 | 0.010 |
Why?
|
| Lung | 1 | 2010 | 9858 | 0.010 |
Why?
|
| Gadolinium | 1 | 1996 | 950 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1995 | 1894 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 969 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2008 | 12718 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4568 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 13869 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20121 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 10940 | 0.000 |
Why?
|
| Skin | 1 | 2000 | 4372 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 57744 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 77410 | 0.000 |
Why?
|